Back to BlackRock, Inc. BlackRock, Inc.

PCRXPCRX
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in PACIRA BIOSCIENCES INC

BlackRock, Inc. holds 6.7M shares of PCRX (PACIRA BIOSCIENCES INC), worth $170.1M as of 2026-Q2. The position was decreased (-0.4% shares). PCRX represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$170.1M

Current Shares

6.7M

Total Value Change

+$24.9M

Total Shares Change

-1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
6.7M
-0.4%
$170.1M0.0%$25.37
0
2026-Q1
Decreased
6.7M
-4.7%
$152.2M0.0%$22.10
0
2025-Q4
Decreased
7.1M
-3.7%
$182.8M0.0%$26.07
0
2025-Q3
Decreased
7.3M
-5.9%
$189.1M0.0%$25.34
0
2025-Q2
Increased
7.8M
+1.9%
$186.3M0.0%$23.48
31
2025-Q1
Decreased
7.7M
-0.7%
$190.2M0.0%$24.91
0
2024-Q4
New
7.7M
-
$145.3M0.0%$18.94
42

Other major holders of PCRX: BNP PARIBAS FINANCIAL MARKETS, MACQUARIE GROUP LTD, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used